About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Management of Hypertension and Hyperlipidemia in Type 2 Diabetes
By
Cleveland Clinic | 12th Annual Obesity Summit
FEATURING
Steven Nissen
December 3, 2017
2 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
Cardiometabolic Health Congress (CMHC)
CMHC Masterclass: Addressing Cardiometabolic Risk in Children and Adoles...
Thu, Jan 28, 2021
06:38
Allan Jaffe
What Does Elevated Troponin Mean in COVID-19?
16:57
William White
Ambulatory Blood Pressure Monitoring
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition
Feat.
R. DeFronzo
28:13
National Lipid Association
New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Aci...
Feat.
R. Mason
18:25
ARCH Advanced Revascularization Symposium
Hypertension 2016: Guidelines and Updates
42:25
Piedmont Heart Institute
Peripheral Arterial Disease: How To Prevent? When To Diagnose? How To Tr...
Feat.
A. Klein
28:22
Richard Auchus
Primary Aldosteronism and Implications for Primary Hypertension
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
15:08
Cardiology Pulse 2019
Top 5 Cardiovascular Prevention Trials
Feat.
R. Chilton
17:04
Cardiometabolic Health Congress (CMHC)
Part 2 - What Have We Learned from the CANTOS Trial and Looking Forward?
15:25
Javed Butler
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
Cleveland Clinic Heart, Vascular and Thoracic Institute
Effect of Left Ventricular Conduction Delay on Cardiovascular Mortality
Feat.
D. Cantillon
29:14
Michael Ozner
The Role of Omega-3 Fatty Acids for the Treatment and Prevention of Card...
28:09
ASPC 2019 Congress on CVD Prevention
LDL-C lowering and the Brain: Differentiating Fact from Fiction
Feat.
P. Toth
09:38
George Bakris
Hyperkalemia in Chronic Kidney Disease
05:11
Venous Symposium
What Are the Factors Associated with the Increased Severity of Chronic V...
Feat.
T. Urbanek
16:12
ASPC 2018 Congress on CVD Prevention
Debate – Pro – Lipoprotein(a) – Should Be Measured In All Patients At Hi...
Feat.
P. Moriarty
13:57
American Heart & Vascular Institute
Update on Lipid Management for ASCVD Prevention: What Is New in the Chol...
Feat.
E. Brinton
18:43
Bonita Falkner
Recent Advances in Pediatric Hypertension
16:23
Cardiometabolic Health Congress (CMHC)
Part 1 - Targeting Inflammation- Updates on Pathophysiology and Clinical...
Feat.
P. Libby